Five out of sixty-nine patients with Multiple Myeloma (MM) were diagno
sed during the last ten years with Nonsecretory Multiple Myeloma (NSM)
, a rare type of MM. In those patients, M-paraprotein was not detectab
le in their serum or urine. Apart from bone marrow plasmacytosis all h
ad a marked depression of normal immunoglobins and bone lytic lesions,
One patient (Case I) had anaplastic myeloma, which is the most aggres
sive type of myeloma. Two patients (Case I and II) had clinical sympto
ms of hypercalcemia at the time of diagnosis. These cases IgG-kappa an
d another (Case V), had IgG-gamma light chains in cytoplasma of plasma
cells. Four patients received traditional therapy with melphalan-pred
nisone and the patient with anaplastic myeloma received VAD (Vincristi
ne Adriamycin and Dexamethasone). All responsed to therapy - except th
e patient with anaplastic myeloma who died eight months later - and ar
e alive in partial remission from 1 to 4 years.